InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Nussbaum Ran, 董事. Director active across 4 companies, notably Eloxx Pharmaceuticals, Inc.. In total, 11 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €1.4m. History available since 13 May 2021. The latest transaction was filed on 4 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Nussbaum Ran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
411,681 股Common StockSEC:0001609805-25-000006:0
5,250 股0Common StockSEC:0001415889-25-015976:0
47,999 股@ US$5.9446.2% 占其流量Ordinary SharesSEC:0001437749-23-004868:0
1,030 股@ US$5.000.8% 占其流量Ordinary SharesSEC:0001437749-23-004870:0
2,211 股@ US$5.001.7% 占其流量Ordinary SharesSEC:0001437749-23-004866:0
3,539 股100.0% 占其流量Common StockSEC:0001209191-22-059052:0
47,999 股@ US$5.9446.2% 占其流量Ordinary SharesSEC:0001437749-22-024711:0
1,030 股@ US$5.000.8% 占其流量Ordinary SharesSEC:0001437749-22-021338:0
2,211 股@ US$5.002.9% 占其流量Ordinary SharesSEC:0001209191-21-039132:0
1,030 股@ US$5.001.4% 占其流量Ordinary SharesSEC:0001209191-21-039137:0
1,280,624 股@ US$1.35100.0% 占其流量Common StockSEC:0001104659-21-067335:0
标准退出：2021年8月11日 (T+90)
11 条申报中的 11 条
About Nussbaum Ran
Ran Nussbaum is a Board Member at Eloxx Pharmaceuticals, Inc. and UroGen Pharma Ltd. He is responsible for overseeing the operations and strategy of these companies. His experience in the pharmaceutical sector allows him to make significant contributions to strategic discussions. As a board member, he ensures that decisions made align with the growth and innovation objectives of the companies.
